Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents

E-ISSN： 1875-5607|17|10|869-901

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.17, Iss.10, 2017-06, pp. : 869-901

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diaryl Urea: A Privileged Structure in Anticancer Agents

Current Medicinal Chemistry, Vol. 23, Iss. 15, 2016-05 ,pp. : 1528-1548

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of Pyrido[2,3-d] Pyrimidine Derivatives as Potential Anticancer Agents

Letters in Drug Design & Discovery, Vol. 15, Iss. 12, 2018-12 ,pp. : 1240-1251

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Cyclin-Dependent Kinase Inhibition. Purine-Based Derivatives as Anti-Cancer Agents. Roles and Perspectives for the Future

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1037-1050

Bentham Science Publishers

Access to resources Recommend Favorite

Benzimidazole Derivatives as Potential Anticancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 3, 2013-03 ,pp. : 399-407

Bentham Science Publishers

Access to resources Recommend Favorite

Sulfonamides and Sulfonylated Derivatives as Anticancer Agents

Current Cancer Drug Targets, Vol. 2, Iss. 1, 2002-03 ,pp. : 55-75

Bentham Science Publishers

Access to resources Recommend Favorite